Showing results (1341-1350 of 1,708) with videos related to

Sort By:
Pageof 171
Journal of Clinical Lipidology|July 3, 2024
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES studyVera A Bittner, Gregory G Schwartz, Deepak L Bhatt, et al.
JACC. Advances|June 28, 2024
Pathophysiology of Preeclampsia-Induced Vascular Dysfunction and Implications for Subclinical Myocardial Damage and Heart FailureLeslee J Shaw, Krishna Patel, Anuradha Lala-Trindade, et al.
Journal of the American College of Cardiology|March 16, 2018
Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS TrialSonia S Anand, Francois Caron, John W Eikelboom, et al.
Circulation. Cardiovascular Quality and Outcomes|November 12, 2019
Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES TrialMichael Szarek, Ph Gabriel Steg, Dina DiCenso, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Complete Heart Block Complicating ST-Segment Elevation Myocardial Infarction: Temporal Trends and Association With In-Hospital OutcomesPrakash Harikrishnan, Tanush Gupta, Chandrasekar Palaniswamy, et al.
Journal of the American Society of Hypertension : JASH|September 13, 2015
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trialJohn M Flack, Deepak L Bhatt, David E Kandzari, et al.
Clinical Cardiology|October 9, 2019
Design and rationale of the North Indian ST-Segment Elevation Myocardial Infarction Registry: A prospective cohort studySameer Arora, Arman Qamar, Puneet Gupta, et al.
Pageof 171